Architecture, inputs, draft intended use, training and evaluation data, retrospective research results and known limitations.
To be published once the licence question for its source data is settled.
Provenance, composition, collection process and known gaps for ADNI and Bio-Hermes-001 as used in NFAD.
Summary of hazards, foreseeable misuse and mitigations, structured after ISO 14971.
Methods and retrospective results for NFAD, including the data-leakage correction made during development.
Documents on this page describe research software and are published for transparency. They are not instructions for use, performance claims, or evidence of regulatory approval. Corrections and questions: regulatory@algo-md.com.